Open AccessChronic desipramine treatment rescues depression‐related, social and cognitive deficits in Engrailed‐2 knockout mice
Author(s) -
Brielmaier J.,
Senerth J. M.,
Silverman J. L.,
Matteson P. G.,
Millonig J. H.,
DiCiccoBloom E.,
Crawley J. N.
Publication year - 2014
Publication title -
genes, brain and behavior
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.315
H-Index - 91
eISSN - 1601-183X
pISSN - 1601-1848
DOI - 10.1111/gbb.12115
Subject(s) - desipramine , monoaminergic , psychology , neuroscience , antidepressant , sensory gating , behavioural despair test , endocrinology , medicine , serotonin , gating , hippocampus , receptor
Engrailed‐2 ( En2 ) is a homeobox transcription factor that regulates neurodevelopmental processes including neuronal connectivity and elaboration of monoaminergic neurons in the ventral hindbrain. We previously reported abnormalities in brain noradrenergic concentrations in En2 null mutant mice that were accompanied by increased immobility in the forced swim test, relevant to depression. An EN2 genetic polymorphism has been associated with autism spectrum disorders, and mice with a deletion in En2 display social abnormalities and cognitive deficits that may be relevant to multiple neuropsychiatric conditions. This study evaluated the ability of chronic treatment with desipramine ( DMI ), a selective norepinephrine ( NE ) reuptake inhibitor and classical antidepressant, to reverse behavioral abnormalities in En2 −/− mice. Desipramine treatment significantly reduced immobility in the tail suspension and forced swim tests, restored sociability in the three‐chambered social approach task and reversed impairments in contextual fear conditioning in En2 −/− mice. Our findings indicate that modulation of brain noradrenergic systems rescues the depression‐related phenotype in En2 −/− mice and suggest new roles for NE in the pathophysiology of the social and cognitive deficits seen in neuropsychiatric disorders such as autism or schizophrenia .